MetLife Investment Management’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-11,591
| Closed | -$98.6K | – | 2579 |
|
|
2021
Q3 | $98.6K | Hold |
11,591
| – | – | ﹤0.01% | 2445 |
|
|
2021
Q2 | $190K | Hold |
11,591
| – | – | ﹤0.01% | 2199 |
|
|
2021
Q1 | $256K | Hold |
11,591
| – | – | ﹤0.01% | 1912 |
|
|
2020
Q4 | $359K | Hold |
11,591
| – | – | ﹤0.01% | 1653 |
|
|
2020
Q3 | $236K | Buy |
11,591
+3,380
| +41% | +$68.7K | ﹤0.01% | 1764 |
|
|
2020
Q2 | $126K | Buy |
+8,211
| New | +$126K | ﹤0.01% | 2146 |
|